Several mechanisms of IRRs induced by rituximab have been reported: immunoglobulin E (IgE)-mediated hypersensitivity, anaphylactoid reaction (IgE-independent allergic reaction), and cytokine release syndrome (CRS) [18]. The gene discussed is IGHE; the disease is allergic disease.